What are the common causes of hypercholesterolemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Causes of Elevated Cholesterol

Primary (Genetic) Causes

Familial hypercholesterolemia (FH) is the most important genetic cause to identify, affecting approximately 1 in 200-500 individuals, caused by mutations in LDLR, APOB, or PCSK9 genes that impair LDL cholesterol clearance. 1, 2 This autosomal dominant disorder presents with LDL cholesterol typically 190-250+ mg/dL, tendon xanthomas, premature coronary disease (men <55 years, women <65 years), and family history of hypercholesterolemia or early cardiovascular events. 1, 2

Monogenic Disorders

  • LDLR gene mutations account for the majority of FH cases, with approximately 700 different mutations identified worldwide causing deficient or defective LDL receptors. 1, 2

  • APOB gene mutations cause familial defective apolipoprotein B-100 (FDB) in approximately 3% of FH patients, producing a milder phenotype than LDLR-FH. 1, 2

  • PCSK9 gene mutations cause increased degradation of LDL receptors, reducing receptor numbers on cell surfaces. 1, 2

  • Familial combined hyperlipidemia (FCHL) is a genetically complex disorder affecting 1-2% of white populations, characterized by increased apolipoprotein B production with variable elevations in cholesterol, triglycerides, or both in patients and first-degree relatives. 1

Polygenic Hypercholesterolemia

  • Polygenic causes account for many cases of severe hypercholesterolemia where no single-gene defect is identified, resulting from multiple genetic variants combined with environmental factors. 3, 4

  • Genetically elevated remnant cholesterol shows a 2.8-fold causal risk increase for ischemic heart disease per 1-mmol/L increase. 2

Secondary (Acquired) Causes

Secondary causes must always be excluded before attributing hypercholesterolemia to genetic factors, as treating the underlying condition may normalize lipid levels. 1, 2

Endocrine and Metabolic Disorders

  • Hypothyroidism is a common and reversible cause of elevated cholesterol that should be screened in all patients with hypercholesterolemia. 1

  • Diabetes mellitus and glucose intolerance are associated with hypercholesterolemia in 70% of adults with diagnosed diabetes and 77% with undiagnosed diabetes. 5

  • Obesity and metabolic syndrome greatly increase apolipoprotein B production, particularly in patients with FCHL, and are strongly associated with elevated cholesterol when genetic predisposition is absent. 1, 4

Medications

  • Thiazide diuretics can elevate cholesterol levels. 1

  • Beta-blockers (particularly atenolol) may worsen lipid profiles; carvedilol is preferred in patients with hypertriglyceridemia. 1

  • Oral estrogens (but not transdermal) can elevate triglycerides and affect cholesterol metabolism. 1

  • Corticosteroids are a well-recognized cause of secondary hypercholesterolemia. 1

  • Atypical antipsychotics can significantly elevate lipid levels. 1

  • Protease inhibitors, retinoic acid drugs, sirolimus, tamoxifen, and raloxifene are additional medication-related causes. 1

Renal and Hepatic Disorders

  • Nephrotic syndrome and chronic kidney disease commonly cause secondary hypercholesterolemia. 1

  • Cholestatic liver disease impairs bile acid metabolism and can elevate cholesterol. 1

Lifestyle and Dietary Factors

Dietary factors—particularly high saturated fat intake, dietary cholesterol, and obesity—clearly raise cholesterol levels and are important causes of borderline-high cholesterol in the general population. 6

  • Saturated fatty acid intake >7% of total calories is a major modifiable dietary cause of elevated LDL cholesterol. 1, 7

  • Excess dietary cholesterol contributes to hypercholesterolemia, particularly in genetically susceptible individuals. 6

  • Physical inactivity and sedentary lifestyle contribute to unfavorable lipid profiles. 7, 4

  • Excess alcohol consumption can affect lipid metabolism, particularly triglycerides. 1, 7

  • Unfavorable lifestyle patterns are significantly associated with severe hypercholesterolemia in young women without genetic predisposition. 4

Age-Related and Hormonal Factors

  • Age-related decline in LDL receptor activity contributes importantly to borderline-high cholesterol levels and cannot be ignored. 6

  • Postmenopausal estrogen loss causes decreased LDL receptor synthesis and is an important contributor to elevated cholesterol in postmenopausal women. 6

  • Pregnancy (especially third trimester) can cause marked triglyceride elevation in susceptible patients. 1

Critical Clinical Pitfalls

The most dangerous pitfall is failing to identify familial hypercholesterolemia early, as these patients require aggressive lifelong treatment starting in childhood to prevent premature cardiovascular death. 7, 8 Consider FH in any patient with LDL cholesterol ≥190 mg/dL without secondary causes, especially with family history of premature coronary disease or hypercholesterolemia. 2

  • Never assume severe hypercholesterolemia is purely dietary—17% of young women with LDL ≥99th percentile have monogenic familial hypercholesterolemia requiring genetic counseling and family screening. 4

  • Always screen for hypothyroidism before initiating lipid-lowering therapy, as this is a completely reversible cause. 1

  • Review medication lists carefully—many commonly prescribed drugs elevate cholesterol and may be modifiable. 1

  • Recognize that multiple factors often coexist—severe hypercholesterolemia typically results from at least two defects in LDL metabolism (genetic plus environmental), requiring combination drug therapy. 6, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Genetic Basis of High Cholesterol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Familial Hyperlipidemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Familial hypercholesterolemia.

Cardiology clinics, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.